University of Kansas researchers establish potential benefits of high-dose vitamin C for ovarian cancer patients
- Posted: February 6, 2014
University of Kansas Medical Center researchers say a pilot clinical trial shows potential benefits of complementary treatment with high-dose vitamin C for ovarian cancer patients.
Click here to read the full press release.
Among the research institutions NCI funds across the United States, it currently designates 68 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.